NASH is the 2nd leading indication for liver transplants
from Hep Treatment News
Non-alcoholic steatohepatitis (NASH) is the second most common — and fastest-growing — indication for liver transplants in the United States, according to a study in Clinical Gastroenterology and Hepatology. Moreover, among women without hepatocellular carcinoma (HCC), NASH is already the leading reason for a liver transplant. Changing trends in obesity and the development of better treatments for viral hepatitis have altered the picture of chronic liver disease in the United States.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063